Hilleman Laboratories
PrivateLast Round
Grant
Jan 22, 2026
Total Funding Raised
$32.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hilleman Laboratories is a biopharmaceutical company that develops affordable vaccines and biologics for infectious diseases prevalent in low- and middle-income countries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
Nonprofit or NGO
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hilleman Laboratories Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hilleman Laboratories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2026 | ||||
| Corporate Funding | Dec 6, 2021 | ||||
| Grant | Apr 1, 2021 | ||||
| Grant | Sep 28, 2017 | ||||
| Joint Venture | Sep 16, 2009 |
Hilleman Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| Gates Foundation | Grant |
| Vinnova | Grant |
| Singapore Economic Development Board | Corporate Funding |
| Bill & Melinda Gates Foundation | Grant |
| Wellcome Trust | Joint Venture |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
$30M raised from CEPI
- Jun 22, 2024
Grew 15% QoQ, from 52 to 60 employees.
Hilleman Laboratories Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hilleman Laboratories's valuation, stock price, and market status.